Cited by 205Birth, Development, and HealthEpigenetics and DNA MethylationPancreatic function and diabetes

Epigenetic mechanisms in the development of type 2 diabetes

Open access
Pinney, Sara E., Simmons, Rebecca A.·2010·Trends in Endocrinology & Metabolism

Abstract

Type 2 diabetes (T2D) is a disorder of complex genetics influenced by interactions between susceptible genetic loci and environmental perturbations. Intrauterine growth retardation is one such environmental perturbation linked to the development of T2D in adulthood. An abnormal metabolic intrauterine milieu affects fetal development by permanently modifying expression of key genes regulating beta-cell development (Pdx1) and glucose transport (Glut4) in muscle. Epigenetic regulation of gene expression is one mechanism by which genetic susceptibility and environmental insults can lead to T2D. Therefore, therapeutic agents targeting epigenetic gene regulation can ultimately be used to treat T2D; however, there is much to be learned about genome-wide epigenetic programming of health and disease before these therapies can be used in patient care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tem.2009.10.002

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Loss of β-cell mass in growth-restricted rats has been linked to epigenetic downregulation of Pdx1, which is essential for normal β-cell differentiation.

    “This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [79]

    The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

2 of the 66 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [5]Ravelli AC van Der Meulen JH Osmond C Barker DJ Bleker OP 1999 The American Journal of Clinical Nutrition 70 5 811 816 10539740
  2. [13]Cedar H Bergman Y 2009 Linking DNA methylations and histone modifications: patterns and paradigms Nature Reviews Genetics 10 295 304 19308066
  3. [38]Fu Q 2004 Uteroplacental insufficiency induces site-specific changes in histone H3 covalent modifications and affects DNA-histone H3 positioning in day 0 IUGR rat liver Physiological Genomics 20 108 116 15494474
  4. [41]Simmons RA 2001 Intrauterine Growth Retardation Leads to Type II Diabetes in Adulthood in the Rat Diabetes 50 2279 2286 11574409

Cited by

Sorted by citations

Authors
Pinney, S. E., & Simmons, R. A.
Affiliations
Children's Hospital of Philadelphia (US)
Venue
Trends in Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2010-04
Volume
21
Issue
4
Pages
223-229
ISSN
1043-2760 (ISSN-L)
OpenAlex
W1977200537
Cited by
205
References
66
Citations by year
2026: 6 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 11 · 2017: 13 · 2016: 14 · 2015: 17 · 2014: 22 · 2013: 27 · 2012: 19
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • Trends in Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG020898)
  • National Institute of Diabetes and Digestive and Kidney Diseases (L40 DK079770, R01DK055704, DK-55704)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD0432545)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
type 2 diabetes, epigenetic regulation, fetal growth restriction, fetal programming, beta-cell development, PDX1, GLUT4, gene-environment interaction, epigenetic therapy, gene expression
MeSH terms
Diabetes Mellitus, Type 2, Fetal Growth Retardation, Gene Expression Regulation, Histones, Humans, Trans-Activators, Oxidative Stress, Homeodomain Proteins, Chromatin Assembly and Disassembly, Epigenesis, Genetic, Glucose Transporter Type 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review